Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), accountable for causing the coronavirus diseases 2019 (COVID-19), is already declared as a pandemic disease globally. Like previously reported SARS-CoV strain, the novel SARS-CoV-2 also initiates the viral pathogenesis via docking viral spike-protein with the membranal angiotensin-converting enzyme 2 (ACE2) - a receptor on variety of cells in the human body. Therefore, COVID-19 is broadly characterized as a disease that targets multiple organs, particularly causing acute complications via organ-specific pathogenesis accompanied by destruction of ACE2+ cells, including alveolus, cardiac microvasculature, endothelium, and glomerulus. Under such circumstances, the high expression of ACE2 in predisposing individuals associated with anomalous production of the renin-angiotensin system (RAS) may promote enhanced viral load in COVID-19, which comparatively triggers excessive apoptosis. Furthermore, multi-organ injuries were found linked to altered ACE2 expression and inequality between the ACE2/angiotensin-(1-7)/mitochondrial Ang system (MAS) and renin-angiotensin-system (RAS) in COVID-19 patients. However, the exact pathogenesis of multi-organ damage in COVID-19 is still obscure, but several perspectives have been postulated, involving altered ACE2 expression linked with direct/indirect damages by the virus-induced immune responses, such as cytokinin storm. Thus, insights into the invasion of a virus with respect to ACE2 expression site can be helpful to simulate or understand the possible complications in the targeted organ during viral infection. Hence, this review summarizes the multiple organs invasion by SARS CoV-2 linked with ACE2 expression and their consequences, which can be helpful in the management of the COVID-19 pathogenesis under life-threatening conditions.

Centre for Bioinformatics Computational and Systems Biology Pathfinder Research and Training Foundation Greater Noida India

Department of Life Sciences Parul Institute of Applied Sciences Parul University Limda Vadodara India

Laboratory of Ligand Engineering Institute of Biotechnology of the Czech Academy of Sciences v v i BIOCEV Research Center Vestec Czech Republic

NMDC International Inoculation Centre New Delhi India

School of Biotechnology Jawaharlal Nehru University New Delhi India; Centre for Bioinformatics Computational and Systems Biology Pathfinder Research and Training Foundation Greater Noida India

School of Life Sciences Gwangju Institute of Science and Technology Gwangju Republic of Korea

Zobrazit více v PubMed

Abdoli A., Aalizadeh R., Aminianfar H., Kianmehr Z., Teimoori A., Azimi E., Emamipour N., Eghtedardoost M., Siavashi V., Jamshidi H., Hosseinpour M., Taqavian M., Jalili H. Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: a preclinical study. Rev. Med. Virol. 2021 doi: 10.1002/rmv.2305. PubMed DOI PMC

Administration U.S.F.A.D. FDA issues emergency use authorization for third COVID-19 vaccine. FDA News Release. 2021;26:1–5.

Adukia S.A., Ruhatiya R.S., Maheshwarappa H.M., Manjunath R.B., Jain G.N. Extrapulmonary features of COVID-19: a concise review. Indian J. Crit. Care Med. 2020;24:575–580. PubMed PMC

Ahmad I., Rathore F.A. Neurological manifestations and complications of COVID-19: a literature review. J. Clin. Neurosci. 2020;77:8–12. PubMed PMC

Alanio A., Dellière S., Fodil S., Bretagne S., Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir. Med. 2020;8:e48–e49. PubMed PMC

Andersson M.I., Arancibia-Carcamo C.V., Auckland K., Baillie J.K., Barnes E., Beneke T., Bibi S., Brooks T., Carroll M., Crook D., Dingle K., Dold C., Downs L.O., Dunn L., Eyre D.W., Gilbert Jaramillo J., Harvala H., Hoosdally S., Ijaz S., James T., James W., Jeffery K., Justice A., Klenerman P., Knight J.C., Knight M., Liu X., Lumley S.F., Matthews P.C., McNaughton A.L., Mentzer A.J., Mongkolsapaya J., Oakley S., Oliveira M.S., Peto T., Ploeg R.J., Ratcliff J., Robbins M.J., Roberts D.J., Rudkin J., Russell R.A., Screaton G., Semple M.G., Skelly D., Simmonds P., Stoesser N., Turtle L., Wareing S., Zambon M. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020;5:181. PubMed PMC

Arora G., Kassir M., Jafferany M., Galadari H., Lotti T., Satolli F., Sadoughifar R., Sitkowska Z., Goldust M. The COVID-19 outbreak and rheumatologic skin diseases. Dermatol. Ther. 2020;33:e13357. PubMed PMC

Arshad U., Pertinez H., Box H., Tatham L., Rajoli R.K.R., Curley P., Neary M., Sharp J., Liptrott N.J., Valentijn A., David C., Rannard S.P., O'Neill P.M., Aljayyoussi G., Pennington S.H., Ward S.A., Hill A., Back D.J., Khoo S.H., Bray P.G., Biagini G.A., Owen A. Prioritization of anti-SARS-Cov-2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human pharmacokinetics. Clin. Pharmacol. Ther. 2020;108:775–790. PubMed PMC

Asano M., Okada H., Itoh Y., Hirata H., Ishikawa K., Yoshida E., Matsui A., Kelly E.J., Shoemaker K., Olsson U., Vekemans J. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial. Int. J. Infect. Dis. 2022;114:165–174. PubMed PMC

Assiri A., McGeer A., Perl T.M., Price C.S., Rabeeah A.A., Cummings D.A. Hospital outbreak of middle east respiratory syndrome coronavirus. N. Engl. J. Med. 2013;369 PubMed PMC

Attaway A.H., Scheraga R.G., Bhimraj A., Biehl M., Hatipoğlu U.J.B. 2021. Severe Covid-19 Pneumonia: Pathogenesis and Clinical Management; p. 372. PubMed

Azzi Y., Bartash R., Scalea J., Loarte-Campos P., Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105:37–55. PubMed

Bailey A.L., Dmytrenko O., Greenberg L., Bredemeyer A.L., Ma P., Liu J., Penna V., Winkler E.S., Sviben S., Brooks E., Nair A.P., Heck K.A., Rali A.S., Simpson L., Saririan M., Hobohm D., Stump W.T., Fitzpatrick J.A., Xie X., Zhang X., Shi P.Y., Hinson J.T., Gi W.T., Schmidt C., Leuschner F., Lin C.Y., Diamond M.S., Greenberg M.J., Lavine K.J. SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl. Sci. 2021;6:331–345. PubMed PMC

Baker E.H., Wood D.M., Brennan A.L., Clark N., Baines D.L., Philips B.J. Hyperglycaemia and pulmonary infection. Proc. Nutr. Soc. 2006;65:227–235. PubMed

Banks P.A., Bollen T.L., Dervenis C., Gooszen H.G., Johnson C.D., Sarr M.G., Tsiotos G.G., Vege S.S. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–111. PubMed

Barber E., Kovo M., Leytes S., Sagiv R., Weiner E., Schwartz O., Mashavi M., Holtzman K., Bar J., Engel A., Ginath S. Evaluation of SARS-CoV-2 in the vaginal secretions of women with COVID-19: a prospective study. J. Clin. Med. 2021;10 PubMed PMC

Barnes B.J., Adrover J.M., Baxter-Stoltzfus A., Borczuk A., Cools-Lartigue J., Crawford J.M., Dassler-Plenker J., Guerci P., Huynh C., Knight J.S., Loda M., Looney M.R., McAllister F., Rayes R., Renaud S., Rousseau S., Salvatore S., Schwartz R.E., Spicer J.D., Yost C.C., Weber A., Zuo Y., Egeblad M. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J. Exp. Med. 2020;217 PubMed PMC

Bearse M., Hung Y.P., Krauson A.J., Bonanno L., Boyraz B., Harris C.K., Helland T.L., Hilburn C.F., Hutchison B., Jobbagy S., Marshall M.S., Shepherd D.J., Villalba J.A., Delfino I., Mendez-Pena J., Chebib I., Newton-Cheh C., Stone J.R. Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. Mod. Pathol. 2021;34:1345–1357. PubMed PMC

Beckers E., Chouvel P., Cassetto V., Mustin V. Sudden sensorineural hearing loss in COVID-19: a case report and literature review. Clin. Case Rep. 2021;9:2300–2304. PubMed PMC

Behzad S., Aghaghazvini L., Radmard A.R., Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin. Imaging. 2020;66:35–41. PubMed PMC

Bertram S., Heurich A., Lavender H., Gierer S., Danisch S., Perin P., Lucas J.M., Nelson P.S., Pohlmann S., Soilleux E.J. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 2012;7 PubMed PMC

Beuscher T.L., Andrews S.E. What are COVID toes? A case study. J. Wound Ostom. Contin. Nurs. 2020;47:619–621. PubMed

Bhimraj A., Morgan R.L., Shumaker A.H., Lavergne V., Baden L., Cheng V.C., Edwards K.M., Gandhi R., Muller W.J., O’Horo J.C., Shoham S., Murad M.H., Mustafa R.A., Sultan S., Falck-Ytter Y. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Clin. Infect. Dis. 2020;ciaa478 PubMed PMC

Bian, J., Li, Z., 2020. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm. Sin. B 11(1):1-12. PubMed PMC

Biswas S., Thakur V., Kaur P., Khan A., Kulshrestha S., Kumar P. Blood clots in COVID-19 patients: simplifying the curious mystery. Med. Hypotheses. 2021;146:110371. PubMed PMC

Bocci M., Oudenaarden C., Saenz-Sarda X., Simren J., Eden A., Sjolund J., Moller C., Gisslen M., Zetterberg H., Englund E., Pietras K. Infection of brain pericytes underlying neuropathology of COVID-19 patients. Int. J. Mol. Sci. 2021;22 PubMed PMC

Boulware D.R., Pullen M.F., Bangdiwala A.S., Pastick K.A., Lofgren S.M., Okafor E.C., Skipper C.P., Nascene A.A., Nicol M.R., Abassi M., Engen N.W., Cheng M.P., LaBar D., Lother S.A., MacKenzie L.J., Drobot G., Marten N., Zarychanski R., Kelly L.E., Schwartz I.S., McDonald E.G., Rajasingham R., Lee T.C., Hullsiek K.H. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N. Engl. J. Med. 2020;383:517–525. PubMed PMC

Boyapati A., Wipperman M.F., Ehmann P.J., Hamon S., Lederer D.J., Waldron A., Flanagan J.J., Karayusuf E., Bhore R., Nivens M.C., Hamilton J.D., Sumner G., Sivapalasingam S. Baseline severe acute respiratory syndrome viral load is associated with Coronavirus disease 2019 severity and clinical outcomes: post Hoc analyses of a phase 2/3 trial. J. Infect. Dis. 2021;224:1830–1838. PubMed PMC

Bugge T.H., Antalis T.M., Wu Q. Type II transmembrane serine proteases. J. Biol. Chem. 2009;284:23177–23181. PubMed PMC

Bwire G.M., Majigo M.V., Njiro B.J., Mawazo A. Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: a systematic review and meta-analysis. J. Med. Virol. 2021;93:719–725. PubMed PMC

Caly L., Druce J.D., Catton M.G., Jans D.A., Wagstaff K.M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir. Res. 2020;178 PubMed PMC

Canatan D., Vives Corrons J.L., De Sanctis V. The multifacets of COVID-19 in adult patients: a concise clinical review on pulmonary and extrapulmonary manifestations for healthcare physicians: Covid-19 and pulmonary and extrapulmonary manifestations. Acta Bio. Med. Atenei Parmensis. 2020;91 PubMed PMC

CanSino, Biologics Inc . 2021. CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine in China.

Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T., Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Osterlund P., Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B., Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O., Stadelmann C., Balistreri G., Simons M. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–860. PubMed PMC

Cao J., Tu W.J., Cheng W., Yu L., Liu Y.K., Hu X., Liu Q. Clinical features and short-term outcomes of 102 patients with Coronavirus disease 2019 in Wuhan, China. Clin. Infect. Dis. 2020;71:748–755. PubMed PMC

Caricchio R., Abbate A., Gordeev I., Meng J., Hsue P.Y., Neogi T., Arduino R., Fomina D., Bogdanov R., Stepanenko T., Ruiz-Seco P., Gonzalez-Garcia A., Chen Y., Li Y., Whelan S., Noviello S., Investigators C.-C. Effect of Canakinumab vs Placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial. JAMA. 2021;326:230–239. PubMed PMC

Casey J.D., Johnson N.J., Semler M.W., Collins S.P., Aggarwal N.R., Brower R.G., Chang S.Y., Eppensteiner J., Filbin M., Gibbs K.W., Ginde A.A., Gong M.N., Harrell F., Hayden D.L., Hough C.L., Khan A., Leither L.M., Moss M., Oldmixon C.F., Park P.K., Reineck L.A., Ringwood N.J., Robinson B.R.H., Schoenfeld D.A., Shapiro N.I., Steingrub J.S., Torr D.K., Weissman A., Lindsell C.J., Rice T.W., Thompson B.T., Brown S.M., Self W.H. Rationale and design of ORCHID: a randomized placebo-controlled clinical trial of hydroxychloroquine for adults hospitalized with COVID-19. Ann. Am. Thorac. Soc. 2020;17:1144–1153. PubMed PMC

CDC Moderna COVID-19 vaccine overview and safety. Vaccines. 2021:1–5.

CDC, Centers for Disease Control and Prevention. Atlanta; GA: US Department of Health and Human Services; Division of Cancer Prevention and Control . 2021. Pfizer-BioNTech COVID-19 Vaccine Overview and Safety (also known as COMIRNATY) pp. 1–7.

Chaibi S., Boussier J., Hajj W.E., Abitbol Y., Taieb S., Horaist C., Jouannaud V., Wang P., Piquet J., Maurer C., Lahmek P., Nahon S. Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: results of a French cohort. Clin. Res. Hepatol. Gastroenterol. 2021;45:101556. PubMed PMC

Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., Tsoi H.W., Lo S.K., Chan K.H., Poon V.K., Chan W.M., Ip J.D., Cai J.P., Cheng V.C., Chen H., Hui C.K., Yuen K.Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. PubMed PMC

Chang-Monteagudo A., Ochoa-Azze R., Climent-Ruiz Y., Macias-Abraham C., Rodriguez-Noda L., Valenzuela-Silva C., Sanchez-Ramirez B., Perez-Nicado R., Hernandez-Garcia T., Orosa-Vazquez I., Diaz-Hernandez M., Garcia-Garcia M.L.A., Jerez-Barcelo Y., Triana-Marrero Y., Ruiz-Villegas L., Rodriguez-Prieto L.D., Puga-Gomez R., Guerra-Chaviano P.P., Zuniga-Rosales Y., Marcheco-Teruel B., Rodriguez-Acosta M., Noa-Romero E., Enriquez-Puertas J., Porto-Gonzalez D., Fernandez-Medina O., Valdes-Zayas A., Chen G.W., Herrera-Martinez L., Valdes-Balbin Y., Garcia-Rivera D., Verez-Bencomo V. A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: an open-label phase 1 clinical trial. Lancet Reg. Health Am. 2021;4:100079. PubMed PMC

Chavda V.P., Vora L.K., Vihol D.R. COVAX-19Ⓡ vaccine: completely blocks virus transmission to non-immune individuals. Clin. Complement. Med. Pharmacol. 2021;1:100004. PubMed PMC

Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. PubMed PMC

Chen X., Liao B., Cheng L., Peng X., Xu X., Li Y., Hu T., Li J., Zhou X., Ren B. The microbial coinfection in COVID-19. Appl. Microbiol. Biotechnol. 2020;104:7777–7785. PubMed PMC

Chen J., Liu D., Liu L., Liu P., Xu Q., Xia L., Ling Y., Huang D., Song S., Zhang D., Qian Z., Li T., Shen Y., Lu H. A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49:215–219. PubMed PMC

Chen H., Tong Z., Ma Z., Luo L., Tang Y., Teng Y., Yu H., Meng H., Peng C., Zhang Q., Zhu T., Zhao H., Chu G., Li H., Lu H., Qi X. Gastrointestinal bleeding, but not other gastrointestinal symptoms, Is associated with worse outcomes in COVID-19 patients. Front. Med. 2021:8. PubMed PMC

Chen F., Zhu S., Dai Z., Hao L., Luan C., Guo Q., Meng C., Zhang Y. Effects of COVID-19 and mRNA vaccines on human fertility. Hum. Reprod. 2021;37:5–13. PubMed PMC

Cheng Y., Luo R., Wang K., Zhang M., Wang Z., Dong L., Li J., Yao Y., Ge S., Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829–838. PubMed PMC

Choudhary R., Sharma A.K. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance. New Microbes New Infect. 2020;35:100684. PubMed PMC

Clinicaltrials.gov . 2021. An Open Study on the Safety, Tolerability, and Immunogenicity of “Sputnik Light” Vaccine.

Clinicaltrials.gov . 2021. Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19.

Clouden T.A. Persistent hallucinations in a 46-year-old woman after COVID-19 infection: a case report. Cureus. 2020;12 PubMed PMC

Conklin J., Frosch M.P., Mukerji S.S., Rapalino O., Maher M.D., Schaefer P.W., Lev M.H., Gonzalez R.G., Das S., Champion S.N., Magdamo C., Sen P., Harrold G.K., Alabsi H., Normandin E., Shaw B., Lemieux J.E., Sabeti P.C., Branda J.A., Brown E.N., Westover M.B., Huang S.Y., Edlow B.L. Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19. J. Neurol. Sci. 2021;421:117308. PubMed PMC

Conte G., Avignone S., Carbonara M., Meneri M., Ortolano F., Cinnante C., Triulzi F. COVID-19-associated PRES-like encephalopathy with perivascular gadolinium enhancement. AJNR Am. J. Neuroradiol. 2020;41:2206–2208. PubMed PMC

Control C.F.D. 2021. Prevention, Science Brief: omicron (B. 1.1. 529) Variant. Dec. PubMed

Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N.G., Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 2020;176:104742. PubMed PMC

COVID19 Vaccine Tracker. 2021. https://covid19.trackvaccines.org/vaccines/approved/

Craven J. 2021. COVID-19 Vaccine Tracker. Regulatory Affairs Professionals Society (RAPS) https://www.raps.org/news-and-articles/newsarticles/2020/3/covid-19-vaccine-trackerpp. 1–20.

Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M., Aaron J.G., Claassen J., Rabbani L.E., Hastie J. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–1770. PubMed PMC

Dagan N., Barda N., Kepten E., Miron O., Perchik S., Katz M.A., Hernan M.A., Lipsitch M., Reis B., Balicer R.D. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N. Engl. J. Med. 2021;384:1412–1423. PubMed PMC

Davidson A.M., Wysocki J., Batlle D. Vol. 76. 2020. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor; pp. 1339–1349. PubMed PMC

Desai D., Khan A.R., Soneja M., Mittal A., Naik S., Kodan P., Mandal A., Maher G.T., Kumar R., Agarwal A., Gowda N.R., Kumar P., Pandey S., Pandey R.M., Kumar A., Ray A., Jorwal P., Nischal N., Choudhary A., Brijwal M., Madan K., Lodha R., Sinha S., Dar L., Wig N., Guleria R. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00674-5. PubMed DOI PMC

Di Filippo L., De Lorenzo R., D'Amico M., Sofia V., Roveri L., Mele R., Saibene A., Rovere-Querini P., Conte C. COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study. Clin. Nutr. 2021;40:2420–2426. PubMed PMC

Diao B., Wang C.H., Wang R.S., Feng Z.Q., Zhang J., Yang H., Tan Y.J., Wang H.M., Wang C.S., Liu L., Liu Y., Liu Y.P., Wang G., Yuan Z.L., Hou X.T., Ren L., Wu Y.Z., Chen Y.W. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat. Commun. 2021;12 PubMed PMC

Ding T., Wang T., Zhang J., Cui P., Chen Z., Zhou S., Yuan S., Ma W., Zhang M., Rong Y., Chang J., Miao X., Ma X., Wang S. 2021. Analysis of Ovarian Injury Associated With COVID-19 Disease in Reproductive-Aged Women in Wuhan, China: An Observational Study; p. 8. PubMed PMC

Ella R., Vadrevu K.M., Jogdand H., Prasad S., Reddy S., Sarangi V., Ganneru B., Sapkal G., Yadav P., Abraham P., Panda S., Gupta N., Reddy P., Verma S., Kumar Rai S., Singh C., Redkar S.V., Gillurkar C.S., Kushwaha J.S., Mohapatra S., Rao V., Guleria R., Ella K., Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect. Dis. 2021;21:637–646. PubMed PMC

Emary K.R.W., Golubchik T., Aley P.K., Ariani C.V., Angus B., Bibi S., Blane B., Bonsall D., Cicconi P., Charlton S., Clutterbuck E.A., Collins A.M., Cox T., Darton T.C., Dold C., Douglas A.D., Duncan C.J.A., Ewer K.J., Flaxman A.L., Faust S.N., Ferreira D.M., Feng S., Finn A., Folegatti P.M., Fuskova M., Galiza E., Goodman A.L., Green C.M., Green C.A., Greenland M., Hallis B., Heath P.T., Hay J., Hill H.C., Jenkin D., Kerridge S., Lazarus R., Libri V., Lillie P.J., Ludden C., Marchevsky N.G., Minassian A.M., McGregor A.C., Mujadidi Y.F., Phillips D.J., Plested E., Pollock K.M., Robinson H., Smith A., Song R., Snape M.D., Sutherland R.K., Thomson E.C., Toshner M., Turner D.P.J., Vekemans J., Villafana T.L., Williams C.J., Hill A.V.S., Lambe T., Gilbert S.C., Voysey M., Ramasamy M.N., Pollard A.J., Consortium C.-G.U., Project A., Oxford C.-V.T.G. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021;397:1351–1362. PubMed PMC

Explainer V. 2021. COVID-19 Vaccine (Vero Cell), Inactivated (Sinopharm) pp. 1–6.

Farouk S.S., Fiaccadori E., Cravedi P., Campbell K.N. COVID-19 and the kidney: what we think we know so far and what we don’t. J. Nephrol. 2020:1–6. PubMed PMC

FDA FDA news release: FDA approves first COVID-19 vaccine. FDA News Release. 2021:2–5.

FDA . 2021. Emergency Use Authorization (EUA) of the Janssen Covid-19 vaccine to prevent Coronavirus Disease 2019 (COVID-19) p. 8.

Filatov A., Sharma P., Hindi F., Espinosa P.S. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12 PubMed PMC

Fried J.A., Ramasubbu K., Bhatt R., Topkara V.K., Clerkin K.J., Horn E., Rabbani L., Brodie D., Jain S.S., Kirtane A.J. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930–1936. PubMed PMC

Frigerio C.S., Wolfs L., Fattorelli N., Thrupp N., Voytyuk I., Schmidt I., Mancuso R., Chen W.-T., Woodbury M.E., Srivastava G.J.C.R. Vol. 27. 2019. The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques; pp. 1293–1306. e1296. PubMed PMC

Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72–73. PubMed

Garland V., Kumar A.B., Borum M.L. Gastrointestinal and hepatic manifestations of COVID-19: evolving recognition and need for increased understanding in vulnerable populations. J. Natl. Med. Assoc. 2021;113:142–146. PubMed PMC

Gautret P., Lagier J.C., Parola P., Hoang V.T., Meddeb L., Mailhe M., Doudier B., Courjon J., Giordanengo V., Vieira V.E., Tissot Dupont H., Honore S., Colson P., Chabriere E., La Scola B., Rolain J.M., Brouqui P., Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020;56:105949. PubMed PMC

Gembardt F., Sterner-Kock A., Imboden H., Spalteholz M., Reibitz F., Schultheiss H.P., Siems W.E., Walther T. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides. 2005;26:1270–1277. PubMed PMC

Geriak M., Haddad F., Kullar R., Greenwood K.L., Habib M., Habib C., Willms D., Sakoulas G. Randomized prospective open label study shows no impact on clinical outcome of adding losartan to hospitalized COVID-19 patients with mild hypoxemia. Infect. Dis. Ther. 2021;10:1323–1330. PubMed PMC

Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020;126:1456–1474. PubMed PMC

Giustino G., Croft L.B., Stefanini G.G., Bragato R., Silbiger J.J., Vicenzi M., Danilov T., Kukar N., Shaban N., Kini A., Camaj A., Bienstock S.W., Rashed E.R., Rahman K., Oates C.P., Buckley S., Elbaum L.S., Arkonac D., Fiter R., Singh R., Li E., Razuk V., Robinson S.E., Miller M., Bier B., Donghi V., Pisaniello M., Mantovani R., Pinto G., Rota I., Baggio S., Chiarito M., Fazzari F., Cusmano I., Curzi M., Ro R., Malick W., Kamran M., Kohli-Seth R., Bassily-Marcus A.M., Neibart E., Serrao G., Perk G., Mancini D., Reddy V.Y., Pinney S.P., Dangas G., Blasi F., Sharma S.K., Mehran R., Condorelli G., Stone G.W., Fuster V., Lerakis S., Goldman M.E. Characterization of myocardial injury in patients with COVID-19. J. Am. Coll. Cardiol. 2020;76:2043–2055. PubMed PMC

Goldman J.D., Lye D.C.B., Hui D.S., Marks K.M., Bruno R., Montejano R., Spinner C.D., Galli M., Ahn M.-Y., Nahass R.G. Remdesivir for 5 or 10 days in patients with severe Covid-19. N. Engl. J. Med. 2020;383:1827–1837. PubMed PMC

Golmai P., Larsen C.P., DeVita M.V., Wahl S.J., Weins A., Rennke H.G., Bijol V., Rosenstock J.L. Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19. J. Am. Soc. Nephrol. 2020;31:1944–1947. PubMed PMC

Goren A., Vano-Galvan S., Wambier C.G., McCoy J., Gomez-Zubiaur A., Moreno-Arrones O.M., Shapiro J., Sinclair R.D., Gold M.H., Kovacevic M., Mesinkovska N.A., Goldust M., Washenik K. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J. Cosmet. Dermatol. 2020;19:1545–1547. PubMed

Groneberg D.A., Hilgenfeld R., Zabel P.J.R.R. Vol. 6. 2005. Molecular Mechanisms of Severe Acute Respiratory Syndrome (SARS) p. 8. PubMed PMC

Group T.A., Listing E.U., Bbv B.B., Who T., Advisory S., Bbv B.B., Covid W., Roadmap W.H.O.P., Framework W.H.O.V. 2021. The Bharat Biotech BBV152 COVAXIN Vaccine Against COVID-19 : What you Need to Know; pp. 19–22.

Gu J., Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am. J. Pathol. 2007;170 PubMed PMC

Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., Du B., Li L.J., Zeng G., Yuen K.Y., Chen R.C., Tang C.L., Wang T., Chen P.Y., Xiang J., Li S.Y., Wang J.L., Liang Z.J., Peng Y.X., Wei L., Liu Y., Hu Y.H., Peng P., Wang J.M., Liu J.Y., Chen Z., Li G., Zheng Z.J., Qiu S.Q., Luo J., Ye C.J., Zhu S.Y., Zhong N.S., China Medical Treatment Expert Group for, C Clinical characteristics of Coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. PubMed PMC

Guan W.J., Liang W.H., Zhao Y., Liang H.R., Chen Z.S., Li Y.M., Liu X.Q., Chen R.C., Tang C.L., Wang T., Ou C.Q., Li L., Chen P.Y., Sang L., Wang W., Li J.F., Li C.C., Ou L.M., Cheng B., Xiong S., Ni Z.Y., Xiang J., Hu Y., Liu L., Shan H., Lei C.L., Peng Y.X., Wei L., Liu Y., Hu Y.H., Peng P., Wang J.M., Liu J.Y., Chen Z., Li G., Zheng Z.J., Qiu S.Q., Luo J., Ye C.J., Zhu S.Y., Cheng L.L., Ye F., Li S.Y., Zheng J.P., Zhang N.F., Zhong N.S., He J.X. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur. Respir. J. 2020;55 PubMed PMC

Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811–818. PubMed PMC

Guo J., Sheng K., Wu S., Chen H., Xu W. An update on the relationship of SARS-CoV-2 and male reproduction. Front Endocrinol. (Lausanne) 2021;12:788321. PubMed PMC

Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., Freedberg D.E., Kirtane A.J., Parikh S.A., Maurer M.S., Nordvig A.S., Accili D., Bathon J.M., Mohan S., Bauer K.A., Leon M.B., Krumholz H.M., Uriel N., Mehra M.R., Elkind M.S.V., Stone G.W., Schwartz A., Ho D.D., Bilezikian J.P., Landry D.W. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017–1032. PubMed

Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631–637. PubMed PMC

Han B., Song Y., Li C., Yang W., Ma Q., Jiang Z., Li M., Lian X., Jiao W., Wang L., Shu Q., Wu Z., Zhao Y., Li Q., Gao Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect. Dis. 2021;21:1645–1653. PubMed PMC

Harrison C. COVID-19 antiviral pills raise hopes for curbing pandemic. Nat. Biotechnol. 2021 doi: 10.1038/d41587-021-00024-4. PubMed DOI

Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., Consortium C.-G.U., Peacock S.J., Robertson D.L. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 2021;19:409–424. PubMed PMC

He L., Ding Y., Zhang Q., Che X., He Y., Shen H. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006;210 PubMed PMC

Heath P.T., Galiza E.P., Baxter D.N., Boffito M., Browne D., Burns F., Chadwick D.R., Clark R., Cosgrove C., Galloway J., Goodman A.L., Heer A., Higham A., Iyengar S., Jamal A., Jeanes C., Kalra P.A., Kyriakidou C., McAuley D.F., Meyrick A., Minassian A.M., Minton J., Moore P., Munsoor I., Nicholls H., Osanlou O., Packham J., Pretswell C.H., San Francisco Ramos, A, Saralaya D., Sheridan R.P., Smith R., Soiza R.L., Swift P.A., Thomson E.C., Turner J., Viljoen M.E., Albert G., Cho I., Dubovsky F., Glenn G., Rivers J., Robertson A., Smith K., Toback S., nCo, V.S.G Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N. Engl. J. Med. 2021;385:1172–1183. PubMed PMC

Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int. Urol. Nephrol. 2020;52:1193–1194. PubMed PMC

Heuberger J., Trimpert J., Vladimirova D., Goosmann C., Lin M., Schmuck R., Mollenkopf H.J., Brinkmann V., Tacke F., Osterrieder N., Sigal M. Epithelial response to IFN-gamma promotes SARS-CoV-2 infection. EMBO Mol. Med. 2021;13 PubMed PMC

Heyman S.N., Walther T., Abassi Z. Angiotensin-(1-7)-A potential remedy for AKI: insights derived from the COVID-19 pandemic. J. Clin. Med. 2021;10 PubMed PMC

Hikmet F., Mear L., Edvinsson A., Micke P., Uhlen M., Lindskog C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16 PubMed PMC

Hilgenfeld R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014;281:4085–4096. PubMed PMC

Hirsch J.S., Ng J.H., Ross D.W., Sharma P., Shah H.H., Barnett R.L., Hazzan A.D., Fishbane S., Jhaveri K.D., Abate M. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209–218. PubMed PMC

Ho D., Low R., Tong L., Gupta V., Veeraraghavan A., Agrawal R. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul. Immunol. Inflamm. 2020;28:726–734. PubMed

Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e278. PubMed PMC

Hosseinpour M. 2021. Clinical Trial Protocol A double-Blind, Randomized, Placebo-Controlled Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of COVID-19 Inactivated Vaccine (Shifa- Pharmed) in a Population Aged 18 to 75 Years; pp. 1–7.

Hsieh S.M., Liu M.C., Chen Y.H., Lee W.S., Hwang S.J., Cheng S.H., Ko W.C., Hwang K.P., Wang N.C., Lee Y.L., Lin Y.L., Shih S.R., Huang C.G., Liao C.C., Liang J.J., Chang C.S., Chen C., Lien C.E., Tai I.C., Lin T.Y. Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. Lancet Respir. Med. 2021;9:1396–1406. PubMed PMC

Hu R.J., Gao H.M., Huang D., Jiang D.Y., Chen F., Fu B., Yuan X.L., Li J., Jiang Z.X. Successful blood glucose management of a severe COVID-19 patient with diabetes A case report. Medicine. 2020:99. PubMed PMC

Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. PubMed PMC

Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(16-27) PubMed PMC

Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., Crackower M.A., Fukamizu A., Hui C.C., Hein L., Uhlig S., Slutsky A.S., Jiang C., Penninger J.M. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112–116. PubMed PMC

Jacob F., Pather S.R., Huang W.K., Zhang F., Wong S.Z.H., Zhou H., Cubitt B., Fan W., Chen C.Z., Xu M., Pradhan M., Zhang D.Y., Zheng W., Bang A.G., Song H., Carlos de la Torre J., Ming G.L. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell. 2020;27(937-950) PubMed PMC

Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., Singh U., Jagannathan P., Grant P. Patients with uncomplicated Coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin. Infect. Dis. 2021;73:e826–e829. PubMed PMC

Jing Y., Run-Qian L., Hao-Ran W., Hao-Ran C., Ya-Bin L., Yang G., Fei C. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol. Hum. Reprod. 2020;26:367–373. PubMed PMC

Kalil A.C., Mehta A.K., Patterson T.F., Erdmann N., Gomez C.A., Jain M.K., Wolfe C.R., Ruiz-Palacios G.M., Kline S., Regalado Pineda J., Luetkemeyer A.F., Harkins M.S., Jackson P.E.H., Iovine N.M., Tapson V.F., Oh M.D., Whitaker J.A., Mularski R.A., Paules C.I., Ince D., Takasaki J., Sweeney D.A., Sandkovsky U., Wyles D.L., Hohmann E., Grimes K.A., Grossberg R., Laguio-Vila M., Lambert A.A., Lopez de Castilla D., Kim E., Larson L., Wan C.R., Traenkner J.J., Ponce P.O., Patterson J.E., Goepfert P.A., Sofarelli T.A., Mocherla S., Ko E.R., Ponce de Leon A., Doernberg S.B., Atmar R.L., Maves R.C., Dangond F., Ferreira J., Green M., Makowski M., Bonnett T., Beresnev T., Ghazaryan V., Dempsey W., Nayak S.U., Dodd L., Tomashek K.M., Beigel J.H., Members A.-S.G. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir. Med. 2021;9:1365–1376. PubMed PMC

Kalil A.C., Patterson T.F., Mehta A.K., Tomashek K.M., Wolfe C.R., Ghazaryan V., Marconi V.C., Ruiz-Palacios G.M., Hsieh L., Kline S., Tapson V., Iovine N.M., Jain M.K., Sweeney D.A., El Sahly H.M., Branche A.R., Regalado Pineda J., Lye D.C., Sandkovsky U., Luetkemeyer A.F., Cohen S.H., Finberg R.W., Jackson P.E.H., Taiwo B., Paules C.I., Arguinchona H., Erdmann N., Ahuja N., Frank M., Oh M.D., Kim E.S., Tan S.Y., Mularski R.A., Nielsen H., Ponce P.O., Taylor B.S., Larson L., Rouphael N.G., Saklawi Y., Cantos V.D., Ko E.R., Engemann J.J., Amin A.N., Watanabe M., Billings J., Elie M.C., Davey R.T., Burgess T.H., Ferreira J., Green M., Makowski M., Cardoso A., de Bono S., Bonnett T., Proschan M., Deye G.A., Dempsey W., Nayak S.U., Dodd L.E., Beigel J.H., Members A.-S.G. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N. Engl. J. Med. 2021;384:795–807. PubMed PMC

Kang Y., Chen T., Mui D., Ferrari V., Jagasia D., Scherrer-Crosbie M., Chen Y., Han Y. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132. PubMed PMC

Keren-Shaul H., Spinrad A., Weiner A., Matcovitch-Natan O., Dvir-Szternfeld R., Ulland T.K., David E., Baruch K., Lara-Astaiso D., Toth B., Itzkovitz S., Colonna M., Schwartz M., Amit I. A unique microglia type associated with restricting development of Alzheimer's disease. Cell. 2017;169:1276–1290. e1217. PubMed

Khavandi S., Tabibzadeh E., Naderan M., Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Contact Lens Anterior Eye. 2020;43:211. PubMed PMC

Kim S., Liu Y., Lei Z., Dicker J., Cao Y., Zhang X.F., Im W. Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern. J. Chem. Theory Comput. 2021;17(12):7972–7979. PubMed PMC

Klouda T., Hao Y., Kim H., Kim J., Olejnik J., Hume A.J., Ayyappan S., Hong X., Melero-Martin J., Fang Y., Wang Q., Zhou X., Muhlberger E., Jia H., Padera R.F., Jr., Raby B.A., Yuan K. Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2. Angiogenesis. 2021 doi: 10.1007/s10456-021-09823-4. PubMed DOI PMC

Koehler P., Cornely O.A., Böttiger B.W., Dusse F., Eichenauer D.A., Fuchs F., Hallek M., Jung N., Klein F., Persigehl T. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63:528–534. PubMed PMC

Kozlovskaya L.I., Piniaeva A.N., Ignatyev G.M., Gordeychuk I.V., Volok V.P., Rogova Y.V., Shishova A.A., Kovpak A.A., Ivin Y.Y., Antonova L.P., Mefyod K.M., Prokosheva L.S., Sibirkina A.S., Tarasova Y.Y., Bayurova E.O., Gancharova O.S., Illarionova V.V., Glukhov G.S., Sokolova O.S., Shaitan K.V., Moysenovich A.M., Gulyaev S.A., Gulyaeva T.V., Moroz A.V., Gmyl L.V., Ipatova E.G., Kirpichnikov M.P., Egorov A.M., Siniugina A.A., Ishmukhametov A.A. Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerg. Microbes Infect. 2021;10:1790–1806. PubMed PMC

Kreuzberger N., Hirsch C., Chai K.L., Tomlinson E., Khosravi Z., Popp M., Neidhardt M., Piechotta V., Salomon S., Valk S.J., Monsef I., Schmaderer C., Wood E.M., So-Osman C., Roberts D.J., McQuilten Z., Estcourt L.J., Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst. Rev. 2021;9:CD013825. PubMed PMC

Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005:11. PubMed PMC

Kuba K., Imai Y., Penninger J.M.J.C.J. Vol. 77. 2013. Multiple Functions of Angiotensin-Converting Enzyme 2 and its Relevance in Cardiovascular Diseases; pp. 301–308. PubMed

Kui L., Fang Y., Deng Y., Liu W., Wang M., Ma J. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. 2020;133(18):2239–2241. doi: 10.1097/CM9.0000000000000744. PubMed DOI PMC

Kunutsor S.K., Laukkanen J.A. Renal complications in COVID-19: a systematic review and meta-analysis. Ann. Med. 2020;52:345–353. PubMed PMC

Kyrou I., Karteris E., Robbins T., Chatha K., Drenos F., Randeva H.S. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020;18:220. PubMed PMC

Labbe V., Ederhy S., Lapidus N., Salem J.E., Trinh-Duc A., Cohen A., Fartoukh M., Voiriot G. Characterization and outcomes of acute myocardial injury in COVID-19 intensive care patients. Infection. 2021;49:563–566. PubMed PMC

Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L.J.N. Vol. 581. 2020. Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor; pp. 215–220. PubMed

Lang J.P., Wang X., Moura F.A., Siddiqi H.K., Morrow D.A., Bohula E.A. A current review of COVID-19 for the cardiovascular specialist. Am. Heart J. 2020;226:29–44. PubMed PMC

Larsen C.P., Bourne T.D., Wilson J.D., Saqqa O., Sharshir M.A. Collapsing glomerulopathy in a patient with COVID-19. Kidney Int. Rep. 2020;5:935–939. PubMed PMC

Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. 2020;277:2251–2261. PubMed PMC

Ledford H. COVID antiviral pills: what scientists still want to know. Nature. 2021;599:358–359. PubMed

Lee I.T., Nakayama T., Wu C.T., Goltsev Y., Jiang S., Gall P.A., Liao C.K., Shih L.C., Schurch C.M., McIlwain D.R., Chu P., Borchard N.A., Zarabanda D., Dholakia S.S., Yang A., Kim D., Chen H., Kanie T., Lin C.D., Tsai M.H., Phillips K.M., Kim R., Overdevest J.B., Tyler M.A., Yan C.H., Lin C.F., Lin Y.T., Bau D.T., Tsay G.J., Patel Z.M., Tsou Y.A., Tzankov A., Matter M.S., Tai C.J., Yeh T.H., Hwang P.H., Nolan G.P., Nayak J.V., Jackson P.K. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. Nat. Commun. 2020;11:5453. PubMed PMC

Legrand M., Bell S., Forni L., Joannidis M., Koyner J.L., Liu K., Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat. Rev. Nephrol. 2021;17:751–764. PubMed PMC

Lei Y., Zhang J., Schiavon C.R., He M., Chen L., Shen H., Zhang Y., Yin Q., Cho Y., Andrade L., Shadel G.S., Hepokoski M., Lei T., Wang H., Zhang J., Yuan J.X., Malhotra A., Manor U., Wang S., Yuan Z.Y., Shyy J.Y. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ. Res. 2021;128:1323–1326. PubMed PMC

Lescure F.X., Honda H., Fowler R.A., Lazar J.S., Shi G., Wung P., Patel N., Hagino O., Sarilumab C.-G.S.G. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med. 2021;9:522–532. PubMed PMC

Leung W., Chan P., Chan H., Wu A., Lee N. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125 PubMed PMC

Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. PubMed PMC

Li H., Xiao X., Zhang J., Zafar M.I., Wu C., Long Y., Lu W., Pan F., Meng T., Zhao K., Zhou L., Shen S., Liu L., Liu Q., Xiong C. Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine. 2020;28:100604. PubMed PMC

Li N., Zhu L., Sun L., Shao G. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Stem Cell Res. 2021;51:102168. PubMed PMC

Li J., Hou L., Guo X., Jin P., Wu S., Zhu J., Pan H., Wang X., Song Z., Wan J., Cui L., Li J., Wang X., Jin L., Liu J., Shi F., Xu X., Chen Y., Zhu T., Chen W., Zhu F. 2021. Heterologous Prime-Boost Immunization with CoronaVac and Convidecia. 2021.2009.2003.21263062.

Lim S., Bae J.H., Kwon H.S., Nauck M.A. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021;17:11–30. PubMed PMC

Lin N., Zhou X., Geng X., Drewell C., Hubner J., Li Z., Zhang Y., Xue M., Marx U., Li B. Repeated dose multi-drug testing using a microfluidic chip-based coculture of human liver and kidney proximal tubules equivalents. Sci. Rep. 2020;10:8879. PubMed PMC

Lindner D., Fitzek A., Brauninger H., Aleshcheva G., Edler C., Meissner K., Scherschel K., Kirchhof P., Escher F., Schultheiss H.P., Blankenberg S., Puschel K., Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5:1281–1285. PubMed PMC

Liu Y., Fu X., Xie C. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99 PubMed PMC

Liu L., Ni S.Y., Yan W., Lu Q.D., Zhao Y.M., Xu Y.Y., Mei H., Shi L., Yuan K., Han Y., Deng J.H., Sun Y.K., Meng S.Q., Jiang Z.D., Zeng N., Que J.Y., Zheng Y.B., Yang B.N., Gong Y.M., Ravindran A.V., Kosten T., Wing Y.K., Tang X.D., Yuan J.L., Wu P., Shi J., Bao Y.P., Lu L. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action. EClinicalMedicine. 2021;40:101111. PubMed PMC

Livanos A.E., Jha D., Cossarini F., Gonzalez-Reiche A.S., Tokuyama M., Aydillo T., Parigi T.L., Ladinsky M.S., Ramos I., Dunleavy K., Lee B., Dixon R.E., Chen S.T., Martinez-Delgado G., Nagula S., Bruce E.A., Ko H.M., Glicksberg B.S., Nadkarni G., Pujadas E., Reidy J., Naymagon S., Grinspan A., Ahmad J., Tankelevich M., Bram Y., Gordon R., Sharma K., Houldsworth J., Britton G.J., Chen-Liaw A., Spindler M.P., Plitt T., Wang P., Cerutti A., Faith J.J., Colombel J.F., Kenigsberg E., Argmann C., Merad M., Gnjatic S., Harpaz N., Danese S., Cordon-Cardo C., Rahman A., Schwartz R.E., Kumta N.A., Aghemo A., Bjorkman P.J., Petralia F., van Bakel H., Garcia-Sastre A., Mehandru S. Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms. Gastroenterology. 2021;160:2435–2450. e2434. PubMed PMC

Lofgren S.M., Nicol M.R., Bangdiwala A.S., Pastick K.A., Okafor E.C., Skipper C.P., Pullen M.F., Engen N.W., Abassi M., Williams D.A., Nascene A.A., Axelrod M.L., Lother S.A., MacKenzie L.J., Drobot G., Marten N., Cheng M.P., Zarychanski R., Schwartz I.S., Silverman M., Chagla Z., Kelly L.E., McDonald E.G., Lee T.C., Hullsiek K.H., Boulware D.R., Rajasingham R. Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19. Open Forum Infect. Dis. 2020;7 ofaa500. PubMed PMC

Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S., Kovyrshina A.V., Lubenets N.L., Grousova D.M., Erokhova A.S., Botikov A.G., Izhaeva F.M., Popova O., Ozharovskaya T.A., Esmagambetov I.B., Favorskaya I.A., Zrelkin D.I., Voronina D.V., Shcherbinin D.N., Semikhin A.S., Simakova Y.V., Tokarskaya E.A., Egorova D.A., Shmarov M.M., Nikitenko N.A., Gushchin V.A., Smolyarchuk E.A., Zyryanov S.K., Borisevich S.V., Naroditsky B.S., Gintsburg A.L., Gam C.-V.V.T.G. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397:671–681. PubMed PMC

Lopes-Pacheco M., Silva P.L., Cruz F.F., Battaglini D., Robba C., Pelosi P., Morales M.M., Caruso Neves C., Rocco P.R.M. Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front. Physiol. 2021;12:593223. PubMed PMC

Mahmud R., Rahman M.M., Alam I., Ahmed K.G.U., Kabir A., Sayeed S., Rassel M.A., Monayem F.B., Islam M.S., Islam M.M., Barshan A.D., Hoque M.M., Mallik M.U., Yusuf M.A., Hossain M.Z. Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial. J. Int. Med. Res. 2021;49 3000605211013550. PubMed PMC

Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., Miao X., Li Y., Hu B. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690. PubMed PMC

Marchiano S., Hsiang T.Y., Khanna A., Higashi T., Whitmore L.S., Bargehr J., Davaapil H., Chang J., Smith E., Ong L.P., Colzani M., Reinecke H., Yang X., Pabon L., Sinha S., Najafian B., Sniadecki N.J., Bertero A., Gale M., Jr., Murry C.E. SARS-CoV-2 infects human pluripotent stem cell-derived cardiomyocytes, impairing electrical and mechanical function. Stem Cell. Rep. 2021;16:478–492. PubMed PMC

Massoth L.R., Desai N., Szabolcs A., Harris C.K., Neyaz A., Crotty R., Chebib I., Rivera M.N., Sholl L.M., Stone J.R., Ting D.T., Deshpande V. Comparison of RNA in situ hybridization and immunohistochemistry techniques for the detection and localization of SARS-CoV-2 in human tissues. Am. J. Surg. Pathol. 2021;45:14–24. PubMed

Matschke J., Lutgehetmann M., Hagel C., Sperhake J.P., Schroder A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., Dottermusch M., Heinemann A., Pfefferle S., Schwabenland M., Sumner Magruder D., Bonn S., Prinz M., Gerloff C., Puschel K., Krasemann S., Aepfelbacher M., Glatzel M. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919–929. PubMed PMC

McCoy J., Cadegiani F.A., Wambier C.G., Herrera S., Vano-Galvan S., Mesinkovska N.A., Ramos P.M., Shapiro J., Sinclair R., Tosti A., Goren A. 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. J. Eur. Acad. Dermatol. Venereol. 2021;35:e243–e246. PubMed

McCoy J., Wambier C.G., Herrera S., Vano-Galvan S., Gioia F., Comeche B., Ron R., Serrano-Villar S., Iwasiow R.M., Tayeb M.A., Cadegiani F.A., Mesinkovska N.A., Shapiro J., Sinclair R., Goren A. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J. Eur. Acad. Dermatol. Venereol. 2021;35:e15–e17. PubMed PMC

McFee R.B. COVID-19: therapeutics and interventions currently under consideration. Dis. Mon. 2020;66:101058. PubMed PMC

Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Brunink S., Greuel S., Lehmann M., Hassan O., Aschman T., Schumann E., Chua R.L., Conrad C., Eils R., Stenzel W., Windgassen M., Rossler L., Goebel H.H., Gelderblom H.R., Martin H., Nitsche A., Schulz-Schaeffer W.J., Hakroush S., Winkler M.S., Tampe B., Scheibe F., Kortvelyessy P., Reinhold D., Siegmund B., Kuhl A.A., Elezkurtaj S., Horst D., Oesterhelweg L., Tsokos M., Ingold-Heppner B., Stadelmann C., Drosten C., Corman V.M., Radbruch H., Heppner F.L. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168–175. PubMed

Miesbach W. Pathological role of angiotensin II in severe COVID-19. TH Open. 2020;4:e138–e144. PubMed PMC

Momin T., Kansagra K., Patel H., Sharma S., Sharma B., Patel J., Mittal R., Sanmukhani J., Maithal K., Dey A., Chandra H., Rajanathan C.T., Pericherla H.P., Kumar P., Narkhede A., Parmar D. Safety and immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India. EClinicalMedicine. 2021;38:101020. PubMed PMC

Monteil V., Kwon H., Prado P., Hagelkruys A., Wimmer R.A., Stahl M., Leopoldi A., Garreta E., Hurtado Del Pozo C., Prosper F., Romero J.P., Wirnsberger G., Zhang H., Slutsky A.S., Conder R., Montserrat N., Mirazimi A., Penninger J.M. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(905-913) PubMed PMC

Montopoli M., Zumerle S., Vettor R., Rugge M., Zorzi M., Catapano C.V., Carbone G.M., Cavalli A., Pagano F., Ragazzi E., Prayer-Galetti T., Alimonti A. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) Ann. Oncol. 2020;31:1040–1045. PubMed PMC

Nehme A., Zouein F.A., Zayeri Z.D., Zibara K. An update on the tissue renin angiotensin system and its role in physiology and pathology. J. Cardiovasc. Dev. Dis. 2019;6 PubMed PMC

Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D., Xu Y., Cao Z., Gao Z. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. PubMed PMC

Nicol M.R., Boulware D.R., Rajasingham R. Reply to Neves. Clin. Infect. Dis. 2021;73:e1772–e1774. PubMed PMC

Nie X., Qian L., Sun R., Huang B., Dong X., Xiao Q., Zhang Q., Lu T., Yue L., Chen S., Li X., Sun Y., Li L., Xu L., Li Y., Yang M., Xue Z., Liang S., Ding X., Yuan C., Peng L., Liu W., Yi X., Lyu M., Xiao G., Xu X., Ge W., He J., Fan J., Wu J., Luo M., Chang X., Pan H., Cai X., Zhou J., Yu J., Gao H., Xie M., Wang S., Ruan G., Chen H., Su H., Mei H., Luo D., Zhao D., Xu F., Li Y., Zhu Y., Xia J., Hu Y., Guo T. Multi-organ proteomic landscape of COVID-19 autopsies. Cell. 2021;184:775–791. e714. PubMed PMC

Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020;17:543–558. PubMed PMC

Nogrady B. Mounting evidence suggests Sputnik COVID vaccine is safe and effective. Nature. 2021;595:339–340. PubMed

Novavax . 2021. Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial.

Osuchowski M.F., Winkler M.S., Skirecki T., Cajander S., Shankar-Hari M., Lachmann G., Monneret G., Venet F., Bauer M., Brunkhorst F.M., Weis S., Garcia-Salido A., Kox M., Cavaillon J.M., Uhle F., Weigand M.A., Flohe S.B., Wiersinga W.J., Almansa R., de la Fuente A., Martin-Loeches I., Meisel C., Spinetti T., Schefold J.C., Cilloniz C., Torres A., Giamarellos-Bourboulis E.J., Ferrer R., Girardis M., Cossarizza A., Netea M.G., van der Poll T., Bermejo-Martin J.F., Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir. Med. 2021;9:622–642. PubMed PMC

Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11:1620. PubMed PMC

Özveri H., Eren M.T., Kırışoğlu C.E., Sarıgüzel N. Atypical presentation of SARS-CoV-2 infection in male genitalia. Urol. Case Rep. 2020;33 PubMed PMC

Pan P.P., Zhan Q.T., Le F., Zheng Y.M., Jin F. Angiotensin-converting enzymes play a dominant role in fertility. Int. J. Mol. Sci. 2013;14:21071–21086. PubMed PMC

Pang W., Zhang D., Zhang J., Li N., Zheng W., Wang H., Liu C., Yang F., Pang B. Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study. Integr. Med. Res. 2020;9 PubMed PMC

Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J., Sordillo E.M., Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699–702. PubMed PMC

Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad. Med. J. 2021;97:312–320. PubMed PMC

Pascarella S., Ciccozzi M., Zella D., Bianchi M., Benetti F., Benvenuto D., Broccolo F., Cauda R., Caruso A., Angeletti S., Giovanetti M., Cassone A. SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate? J. Med. Virol. 2021;93:6551–6556. PubMed PMC

Patel V.B., Clarke N., Wang Z., Fan D., Parajuli N., Basu R., Putko B., Kassiri Z., Turner A.J., Oudit G.Y. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J. Mol. Cell. Cardiol. 2014;66:167–176. PubMed

Patel S., Rauf A., Khan H., Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed. Pharmacother. 2017;94 PubMed

Pellegrini L., Albecka A., Mallery D.L., Kellner M.J., Paul D., Carter A.P., James L.C., Lancaster M.A. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell. 2020;27:951–961. e955. PubMed PMC

Perez-Bermejo J.A., Kang S., Rockwood S.J., Simoneau C.R., Joy D.A., Silva A.C., Ramadoss G.N., Flanigan W.R., Fozouni P., Li H., Chen P.Y., Nakamura K., Whitman J.D., Hanson P.J., McManus B.M., Ott M., Conklin B.R., McDevitt T.C. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci. Transl. Med. 2021:13. PubMed PMC

Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ. Res. 2004;95:1140–1153. PubMed

Printza A., Katotomichelakis M., Valsamidis K., Metallidis S., Panagopoulos P., Panopoulou M., Petrakis V., Constantinidis J. Smell and taste loss recovery time in COVID-19 patients and disease severity. J. Clin. Med. 2021;10 PubMed PMC

Puelles V.G., Lutgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N., Allweiss L., Chilla S., Heinemann A., Wanner N., Liu S., Braun F., Lu S., Pfefferle S., Schroder A.S., Edler C., Gross O., Glatzel M., Wichmann D., Wiech T., Kluge S., Pueschel K., Aepfelbacher M., Huber T.B. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 2020;383:590–592. PubMed PMC

Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 2020;526:135–140. PubMed PMC

Qian Q., Fan L., Liu W., Li J., Yue J., Wang M., Ke X., Yin Y., Chen Q., Jiang C. Direct evidence of active SARS-CoV-2 replication in the intestine. Clin. Infect. Dis. 2021;73:361–366. PubMed PMC

Radmanesh A., Derman A., Lui Y.W., Raz E., Loh J.P., Hagiwara M., Borja M.J., Zan E., Fatterpekar G.M. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;297:E223–E227. PubMed PMC

Rajasingham R., Bangdiwala A.S., Nicol M.R., Skipper C.P., Pastick K.A., Axelrod M.L., Pullen M.F., Nascene A.A., Williams D.A., Engen N.W., Okafor E.C., Rini B.I., Mayer I.A., McDonald E.G., Lee T.C., Li P., MacKenzie L.J., Balko J.M., Dunlop S.J., Hullsiek K.H., Boulware D.R., Lofgren S.M., Team C. Hydroxychloroquine as pre-exposure prophylaxis for Coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial. Clin. Infect. Dis. 2021;72:e835–e843. PubMed PMC

Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J. Eur. Acad. Dermatol. Venereol. 2020;34:e212–e213. PubMed

Rehman S., Majeed T., Ansari M.A., Al-Suhaimi E.A. Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children. J. Infect. Public Health. 2020;13:1830–1832. PubMed PMC

Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140:1–6. PubMed PMC

Reis F.M., Bouissou D.R., Pereira V.M., Camargos A.F., dos Reis A.M., Santos R.A. Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil. Steril. 2011;95:176–181. PubMed

Rochman N.D., Wolf Y.I., Faure G., Mutz P., Zhang F., Koonin E.V. Ongoing global and regional adaptive evolution of SARS-CoV-2. Proc. Natl. Acad. Sci. U. S. A. 2021;118 PubMed PMC

Ronco C., Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat. Rev. Nephrol. 2020;16:308–310. PubMed PMC

Ronco C., Bellomo R., Kellum J.A. Acute kidney injury. Lancet. 2019;394:1949–1964. PubMed

Rosas I.O., Brau N., Waters M., Go R.C., Hunter B.D., Bhagani S., Skiest D., Aziz M.S., Cooper N., Douglas I.S., Savic S., Youngstein T., Del Sorbo L., Cubillo Gracian A., De La Zerda D.J., Ustianowski A., Bao M., Dimonaco S., Graham E., Matharu B., Spotswood H., Tsai L., Malhotra A. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med. 2021;384:1503–1516. PubMed PMC

Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;109 PubMed PMC

RPCEC Abdala Clinical Trials. 2021. https://rpcec.sld.cu/en/trials/RPCEC00000346-En

Russell C.D., Fairfield C.J., Drake T.M., Turtle L., Seaton R.A., Wootton D.G., Sigfrid L., Harrison E.M., Docherty A.B., de Silva T.I.J.T.L.M. 2021. Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalised with COVID-19 during the First Pandemic Wave from the ISARIC WHO CCP-UK Study: A Multicentre, Prospective Cohort Study. PubMed PMC

Russian, Federation 2021. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=71035dbe-6178-42c0-8d36-aa54e546a65b&t

Salka K., Abutaleb K., Chorvinsky E., Thiruvengadam G., Arroyo M., Gomez J.L., Gutierrez M.J., Pillai D.K., Jaiswal J.K., Nino G. IFN stimulates ACE2 expression in pediatric airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2021;64:515–518. PubMed PMC

Saniasiaya J., Kulasegarah J. Dizziness and COVID-19. Ear Nose Throat J. 2020;100:29–30. PubMed PMC

Santoriello D., Khairallah P., Bomback A.S., Xu K., Kudose S., Batal I., Barasch J., Radhakrishnan J., D'Agati V., Markowitz G. Postmortem kidney pathology findings in patients with COVID-19. J. Am. Soc. Nephrol. 2020;31:2158–2167. PubMed PMC

Santos R., Sampaio W., Alzamora A., Motta-Santos D., Alenina N., Bader M. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7) Physiol. Rev. 2018;98 PubMed PMC

Schurink B., Roos E., Radonic T., Barbe E., Bouman C.S.C., de Boer H.H., de Bree G.J., Bulle E.B., Aronica E.M., Florquin S., Fronczek J., Heunks L.M.A., de Jong M.D., Guo L., du Long R., Lutter R., Molenaar P.C.G., Neefjes-Borst E.A., Niessen H.W.M., van Noesel C.J.M., Roelofs J., Snijder E.J., Soer E.C., Verheij J., Vlaar A.P.J., Vos W., van der Wel N.N., van der Wal A.C., van der Valk P., Bugiani M. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1:e290–e299. PubMed PMC

Schwartz A., Yogev Y., Zilberman A., Alpern S., Many A., Yousovich R., Gamzu R. Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study. BJOG. 2021;128:97–100. PubMed PMC

Scorzolini L., Corpolongo A., Castilletti C., Lalle E., Mariano A., Nicastri E. Comment on the potential risks of sexual and vertical transmission of COVID-19. Clin. Infect. Dis. 2020;71:2298. PubMed PMC

Sedhai Y.R., Sears M., Vecchie A., Bonaventura A., Greer J., Spence K., Tackett H., Turner J., Pak M., Patel N., Black M., Wohlford G., Clary R.E., Duke C., Hardin M., Kemp H., Priday A., Sims E.K., Jr., Mihalick V., Ho A.C., Ibe I., Harmon M., Markley R., Van Tassell B., Abbate A. Clinical trial enrollment at a rural satellite hospital during COVID-19 pandemic. J. Clin. Transl. Sci. 2021;5 PubMed PMC

Self W.H., Semler M.W., Leither L.M., Casey J.D., Angus D.C., Brower R.G., Chang S.Y., Collins S.P., Eppensteiner J.C., Filbin M.R., Files D.C., Gibbs K.W., Ginde A.A., Gong M.N., Harrell F.E., Jr., Hayden D.L., Hough C.L., Johnson N.J., Khan A., Lindsell C.J., Matthay M.A., Moss M., Park P.K., Rice T.W., Robinson B.R.H., Schoenfeld D.A., Shapiro N.I., Steingrub J.S., Ulysse C.A., Weissman A., Yealy D.M., Thompson B.T., Brown S.M., National Heart L., Blood Institute, P.C.T.N, Steingrub J., Smithline H., Tiru B., Tidswell M., Kozikowski L., Thornton-Thompson S., De Souza L., Hou P., Baron R., Massaro A., Aisiku I., Fredenburgh L., Seethala R., Johnsky L., Riker R., Seder D., May T., Baumann M., Eldridge A., Lord C., Shapiro N., Talmor D., O'Mara T., Kirk C., Harrison K., Kurt L., Schermerhorn M., Banner-Goodspeed V., Boyle K., Dubosh N., Filbin M., Hibbert K., Parry B., Lavin-Parsons K., Pulido N., Lilley B., Lodenstein C., Margolin J., Brait K., Jones A., Galbraith J., Peacock R., Nandi U., Wachs T., Matthay M., Liu K., Kangelaris K., Wang R., Calfee C., Yee K., Hendey G., Chang S., Lim G., Qadir N., Tam A., Beutler R., Levitt J., Wilson J., Rogers A., Vojnik R., Roque J., Albertson T., Chenoweth J., Adams J., Pearson S., Juarez M., Almasri E., Fayed M., Hughes A., Hillard S., Huebinger R., Wang H., Vidales E., Patel B., Ginde A., Moss M., Baduashvili A., McKeehan J., Finck L., Higgins C., Howell M., Douglas I., Haukoos J., Hiller T., Lyle C., Cupelo A., Caruso E., Camacho C., Gravitz S., Finigan J., Griesmer C., Park P., Hyzy R., Nelson K., McDonough K., Olbrich N., Williams M., Kapoor R., Nash J., Willig M., Ford H., Gardner-Gray J., Ramesh M., Moses M., Ng Gong M., Aboodi M., Asghar A., Amosu O., Torres M., Kaur S., Chen J.T., Hope A., Lopez B., Rosales K., Young You J., Mosier J., Hypes C., Natt B., Borg B., Salvagio Campbell E., Hite R.D., Hudock K., Cresie A., Alhasan F., Gomez-Arroyo J., Duggal A., Mehkri O., Hastings A., Sahoo D., Abi Fadel F., Gole S., Shaner V., Wimer A., Meli Y., King A., Terndrup T., Exline M., Pannu S., Robart E., Karow S., Hough C., Robinson B., Johnson N., Henning D., Campo M., Gundel S., Seghal S., Katsandres S., Dean S., Khan A., Krol O., Jouzestani M., Huynh P., Weissman A., Yealy D., Scholl D., Adams P., McVerry B., Huang D., Angus D., Schooler J., Moore S., Files C., Miller C., Gibbs K., LaRose M., Flores L., Koehler L., Morse C., Sanders J., Langford C., Nanney K., MdalaGausi M., Yeboah P., Morris P., Sturgill J., Seif S., Cassity E., Dhar S., de Wit M., Mason J., Goodwin A., Hall G., Grady A., Chamberlain A., Brown S., Bledsoe J., Leither L., Peltan I., Starr N., Fergus M., Aston V., Montgomery Q., Smith R., Merrill M., Brown K., Armbruster B., Harris E., Middleton E., Paine R., Johnson S., Barrios M., Eppensteiner J., Limkakeng A., McGowan L., Porter T., Bouffler A., Leahy J.C., deBoisblanc B., Lammi M., Happel K., Lauto P., Self W., Casey J., Semler M., Collins S., Harrell F., Lindsell C., Rice T., Stubblefield W., Gray C., Johnson J., Roth M., Hays M., Torr D., Zakaria A., Schoenfeld D., Thompson T., Hayden D., Ringwood N., Oldmixon C., Ulysse C., Morse R., Muzikansky A., Fitzgerald L., Whitaker S., Lagakos A., Brower R., Reineck L., Aggarwal N., Bienstock K., Freemer M., Maclawiw M., Weinmann G., Morrison L., Gillespie M., Kryscio R., Brodie D., Zareba W., Rompalo A., Boeckh M., Parsons P., Christie J., Hall J., Horton N., Zoloth L., Dickert N., Diercks D. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA. 2020;324:2165–2176. PubMed PMC

Seth V., Kushwaha S. Headache due to COVID-19: a disabling combination. Headache. 2020;60:2618. PubMed PMC

Sharma A., Garcia G., Jr., Wang Y., Plummer J.T., Morizono K., Arumugaswami V., Svendsen C.N. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell. Rep. Med. 2020;1:100052. PubMed PMC

Shen Q., Xiao X., Aierken A., Yue W., Wu X., Liao M., Hua J. The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection. J. Cell. Mol. Med. 2020;24:9472–9477. PubMed PMC

Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., Huang H., Yang B., Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810. PubMed PMC

Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X., Bucci E., Piacentini M., Ippolito G., Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451–1454. PubMed PMC

Skipper C.P., Boulware D.R. Hydroxychloroquine in nonhospitalized adults with early COVID-19. Ann. Intern. Med. 2021;174:434–435. PubMed

Skipper C.P., Pastick K.A., Engen N.W., Bangdiwala A.S., Abassi M., Lofgren S.M., Williams D.A., Okafor E.C., Pullen M.F., Nicol M.R., Nascene A.A., Hullsiek K.H., Cheng M.P., Luke D., Lother S.A., MacKenzie L.J., Drobot G., Kelly L.E., Schwartz I.S., Zarychanski R., McDonald E.G., Lee T.C., Rajasingham R., Boulware D.R. Hydroxychloroquine in nonhospitalized adults with early COVID-19 : a randomized trial. Ann. Intern. Med. 2020;173:623–631. PubMed PMC

Socher E., Conrad M., Heger L., Paulsen F., Sticht H., Zunke F., Arnold P. Computational decomposition reveals reshaping of the SARS-CoV-2–ACE2 interface among viral variants expressing the N501Y mutation. J. Cell. Biochem. 2021;122:1863–1872. PubMed

Sodeifian F., Seyedalhosseini Z.S., Kian N., Eftekhari M., Najari S., Mirsaeidi M., Farsi Y., Nasiri M.J. Drug-induced liver injury in COVID-19 patients: a systematic review. Front. Med. (Lausanne) 2021;8 PubMed PMC

Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., Szigeti-Buck K., Yasumoto Y., Wang G., Castaldi C., Heltke J., Ng E., Wheeler J., Alfajaro M.M., Levavasseur E., Fontes B., Ravindra N.G., Van Dijk D., Mane S., Gunel M., Ring A., Kazmi S.A.J., Zhang K., Wilen C.B., Horvath T.L., Plu I., Haik S., Thomas J.L., Louvi A., Farhadian S.F., Huttner A., Seilhean D., Renier N., Bilguvar K., Iwasaki A. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218 PubMed PMC

Stanifer M.L., Kee C., Cortese M., Zumaran C.M., Triana S., Mukenhirn M., Kraeusslich H.G., Alexandrov T., Bartenschlager R., Boulant S. Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep. 2020;32 PubMed PMC

Stone J.H., Frigault M.J., Serling-Boyd N.J., Fernandes A.D., Harvey L., Foulkes A.S., Horick N.K., Healy B.C., Shah R., Bensaci A.M., Woolley A.E., Nikiforow S., Lin N., Sagar M., Schrager H., Huckins D.S., Axelrod M., Pincus M.D., Fleisher J., Sacks C.A., Dougan M., North C.M., Halvorsen Y.D., Thurber T.K., Dagher Z., Scherer A., Wallwork R.S., Kim A.Y., Schoenfeld S., Sen P., Neilan T.G., Perugino C.A., Unizony S.H., Collier D.S., Matza M.A., Yinh J.M., Bowman K.A., Meyerowitz E., Zafar A., Drobni Z.D., Bolster M.B., Kohler M., D'Silva K.M., Dau J., Lockwood M.M., Cubbison C., Weber B.N., Mansour M.K., Investigators B.B.T.T. Efficacy of tocilizumab in patients hospitalized with Covid-19. N. Engl. J. Med. 2020;383:2333–2344. PubMed PMC

Su S., Jiang S. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2. Signal Transduct Target Ther. 2020;5:71. PubMed PMC

Su H., Yang M., Wan C., Yi L.X., Tang F., Zhu H.Y., Yi F., Yang H.C., Fogo A.B., Nie X., Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219–227. PubMed PMC

Sun D.Q., Wang T.Y., Zheng K.I., Targher G., Byrne C.D., Chen Y.P., Zheng M.H. Subclinical acute kidney injury in COVID-19 patients: a retrospective cohort study. Nephron. 2020;144:347–350. PubMed PMC

Sun J., Zhu A., Li H., Zheng K., Zhuang Z., Chen Z., Shi Y., Zhang Z., Chen S.B., Liu X., Dai J., Li X., Huang S., Huang X., Luo L., Wen L., Zhuo J., Li Y., Wang Y., Zhang L., Zhang Y., Li F., Feng L., Chen X., Zhong N., Yang Z., Huang J., Zhao J., Li Y.M. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg. Microbes Infect. 2020;9:991–993. PubMed PMC

Sungnak W., Huang N., Becavin C., Berg M., Queen R., Litvinukova M., Talavera-Lopez C., Maatz H., Reichart D., Sampaziotis F., Worlock K.B., Yoshida M., Barnes J.L., Network H.C.A.L.B. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681–687. PubMed PMC

Tartof S.Y., Slezak J.M., Fischer H., Hong V., Ackerson B.K., Ranasinghe O.N., Frankland T.B., Ogun O.A., Zamparo J.M., Gray S., Valluri S.R., Pan K., Angulo F.J., Jodar L., McLaughlin J.M. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398:1407–1416. PubMed PMC

Thaweerat W. Current evidence on pancreatic involvement in SARS-CoV-2 infection. Pancreatology. 2020;20:1013–1014. PubMed PMC

Tian R.R., Zhang M.X., Liu M., Fang X., Li D., Zhang L., Zheng P., Zheng Y.T., Liu Y. CD24Fc protects against viral pneumonia in simian immunodeficiency virus-infected Chinese rhesus monkeys. Cell. Mol. Immunol. 2020;17:887–888. PubMed PMC

Tian F., Tong B., Sun L., Shi S., Zheng B., Wang Z., Dong X., Zheng P. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife. 2021;10 PubMed PMC

Toledo-Romani M.E., Garcia-Carmenate M., Silva C.V., Baldoquin-Rodriguez W., Perez M.M., Gonzalez M.C.R., Moreno B.P., Hernandez I.M., Romero R.G.-M., Tabio O.S.J.M. Efficacy and Safety of SOBERANA 02, a COVID-19 conjugate vaccine in heterologous three doses combination. medRxiv. 2021 doi: 10.1101/2021.10.31.21265703. DOI

Tomazini B.M., Maia I.S., Cavalcanti A.B., Berwanger O., Rosa R.G., Veiga V.C., Avezum A., Lopes R.D., Bueno F.R., Silva M., Baldassare F.P., Costa E.L.V., Moura R.A.B., Honorato M.O., Costa A.N., Damiani L.P., Lisboa T., Kawano-Dourado L., Zampieri F.G., Olivato G.B., Righy C., Amendola C.P., Roepke R.M.L., Freitas D.H.M., Forte D.N., Freitas F.G.R., Fernandes C.C.F., Melro L.M.G., Junior G.F.S., Morais D.C., Zung S., Machado F.R., Azevedo L.C.P., Investigators C.C.-B.I. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307–1316. PubMed PMC

Tukhvatulin A.I., Dolzhikova I.V., Shcheblyakov D.V., Zubkova O.V., Dzharullaeva A.S., Kovyrshina A.V., Lubenets N.L., Grousova D.M., Erokhova A.S., Botikov A.G., Izhaeva F.M., Popova O., Ozharovskaia T.A., Esmagambetov I.B., Favorskaya I.A., Zrelkin D.I., Voronina D.V., Shcherbinin D.N., Semikhin A.S., Simakova Y.V., Tokarskaya E.A., Shmarov M.M., Nikitenko N.A., Gushchin V.A., Smolyarchuk E.A., Zubkova T.G., Zakharov K.A., Vasilyuk V.B., Borisevich S.V., Naroditsky B.S., Logunov D.Y., Gintsburg A.L. An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults. Lancet Reg. Health Eur. 2021;11 PubMed PMC

Ulhaq Z.S., Soraya G.V. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefe's Arch. Clinical Exp. Ophthalmol. 2020;258:1351–1352. PubMed PMC

Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. PubMed PMC

Varghese G.M., John R., Manesh A., Karthik R., Abraham O.C. Clinical management of COVID-19. Indian J. Med. Res. 2020;151(5):401–410. doi: 10.4103/ijmr.IJMR_957_20. PubMed DOI PMC

Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;183:1735. PubMed PMC

Wan Y., Shang J., Graham R., Baric R.S., Li F.J.J.O.V. 2020. Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus; p. 94. PubMed PMC

Wang S., Guo F., Liu K., Wang H., Rao S., Yang P., Jiang C. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus Res. 2008;136:8–15. PubMed PMC

Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–1844. PubMed PMC

Wang Y., Liu S., Liu H., Li W., Lin F., Jiang L., Li X., Xu P., Zhang L., Zhao L., Cao Y., Kang J., Yang J., Li L., Liu X., Li Y., Nie R., Mu J., Lu F., Zhao S., Lu J., Zhao J. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J. Hepatol. 2020;73:807–816. PubMed PMC

Wang W., Zhang S., Yang F., Xie J., Chen J., Li Z. Diosmetin alleviates acute kidney injury by promoting the TUG1/Nrf2/HO-1 pathway in sepsis rats. Int. Immunopharmacol. 2020;88 PubMed

Wang M., Luo L., Bu H., Xia H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T-cell count. Int. J. Infect. Dis. 2020;96:148–150. PubMed PMC

Wenzel J., Lampe J., Muller-Fielitz H., Schuster R., Zille M., Muller K., Krohn M., Korbelin J., Zhang L., Ozorhan U., Neve V., Wagner J.U.G., Bojkova D., Shumliakivska M., Jiang Y., Fahnrich A., Ott F., Sencio V., Robil C., Pfefferle S., Sauve F., Coelho C.F.F., Franz J., Spiecker F., Lembrich B., Binder S., Feller N., Konig P., Busch H., Collin L., Villasenor R., Johren O., Altmeppen H.C., Pasparakis M., Dimmeler S., Cinatl J., Puschel K., Zelic M., Ofengeim D., Stadelmann C., Trottein F., Nogueiras R., Hilgenfeld R., Glatzel M., Prevot V., Schwaninger M. The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat. Neurosci. 2021;24:1522–1533. PubMed PMC

WHO . Vol. 4. 2020. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 - 11 March 2020. WHO Dir. Gen. Speeches.

WHO . Vol. 19. 2021. The Moderna COVID-19 (mRNA-1273) Vaccine: What you Need to Know; pp. 2–5.

WHO . 2021. The Sinovac-CoronaVac COVID-19 Vaccine : What you Need to Know; pp. 19–23.

WHO WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations. World Heal. Organ. 2021:21–24.

WHO WHO Coronavirus (COVID-19) 2022. https://covid19.who.int/

Wong C.K., Lam C.W., Wu A.K., Ip W.K., Lee N.L., Chan I.H. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 2004;136 PubMed PMC

Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260–1263. PubMed PMC

Wu P., Duan F., Luo C., Liu Q., Qu X., Liang L., Wu K. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575–578. PubMed PMC

Wu L., Zhou L., Mo M., Liu T., Wu C., Gong C., Lu K., Gong L., Zhu W., Xu Z. SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2. Sig. Transduct. Target. Ther. 2022;7:8. PubMed PMC

Xia S., Zhang Y., Wang Y., Wang H., Yang Y., Gao G.F., Tan W., Wu G., Xu M., Lou Z., Huang W., Xu W., Huang B., Wang W., Zhang W., Li N., Xie Z., Zhu X., Ding L., You W., Zhao Y., Zhao J., Huang L., Shi X., Yang Y., Xu G., Wang W., Liu P., Ma M., Qiao Y., Zhao S., Chai J., Li Q., Fu H., Xu Y., Zheng X., Guo W., Yang X. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect. Dis. 2021;22(2):196–208. PubMed PMC

Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–1833. e1833. PubMed PMC

Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., Li T., Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020;12:8. PubMed PMC

Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., Zhong W., Hao P. Vol. 63. 2020. Evolution of the Novel Coronavirus from the Ongoing Wuhan Outbreak and Modeling of its Spike Protein for Risk of Human Transmission; pp. 457–460. PubMed PMC

Yamaguchi T., Hoshizaki M., Minato T., Nirasawa S., Asaka M.N., Niiyama M., Imai M., Uda A., Chan J.F., Takahashi S., An J., Saku A., Nukiwa R., Utsumi D., Kiso M., Yasuhara A., Poon V.K., Chan C.C., Fujino Y., Motoyama S., Nagata S., Penninger J.M., Kamada H., Yuen K.Y., Kamitani W., Maeda K., Kawaoka Y., Yasutomi Y., Imai Y., Kuba K. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury. Nat. Commun. 2021;12:6791. PubMed PMC

Yan H., Lu S., Chen L., Wang Y., Liu Q., Li D., Yan X., Yan J. Multiple organ injury on admission predicts in-hospital mortality in patients with COVID-19. J. Med. Virol. 2021;93:1652–1664. PubMed PMC

Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91–95. PubMed PMC

Yang L., Han Y., Nilsson-Payant B.E., Gupta V., Wang P., Duan X., Tang X., Zhu J., Zhao Z., Jaffre F., Zhang T., Kim T.W., Harschnitz O., Redmond D., Houghton S., Liu C., Naji A., Ciceri G., Guttikonda S., Bram Y., Nguyen D.T., Cioffi M., Chandar V., Hoagland D.A., Huang Y., Xiang J., Wang H., Lyden D., Borczuk A., Chen H.J., Studer L., Pan F.C., Ho D.D., tenOever B.R., Evans T., Schwartz R.E., Chen S. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27:125–136. e127. PubMed PMC

Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., Calcuttawala K., Vest R.T., Berdnik D., Lu N., Hahn O., Gate D., McNerney M.W., Channappa D., Cobos I., Ludwig N., Schulz-Schaeffer W.J., Keller A., Wyss-Coray T. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565–571. PubMed PMC

Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T., Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y., Li L., Li S. Molecular architecture of the SARS-CoV-2 virus. Cell. 2020;183:730–738. e713. PubMed PMC

Yao X.H., Li T.Y., He Z.C., Ping Y.F., Liu H.W., Yu S.C., Mou H.M., Wang L.H., Zhang H.R., Fu W.J., Luo T., Liu F., Guo Q.N., Chen C., Xiao H.L., Guo H.T., Lin S., Xiang D.F., Shi Y., Pan G.Q., Li Q.R., Huang X., Cui Y., Liu X.Z., Tang W., Pan P.F., Huang X.Q., Ding Y.Q., Bian X.W. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49:411–417. PubMed

Zakarya K., Kutumbetov L., Orynbayev M., Abduraimov Y., Sultankulova K., Kassenov M., Sarsenbayeva G., Kulmagambetov I., Davlyatshin T., Sergeeva M., Stukova M., Khairullin B. Safety and immunogenicity of a QazCovid-in(R) inactivated whole-virion vaccine against COVID-19 in healthy adults: a single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan. EClinicalMedicine. 2021;39:101078. PubMed PMC

Zhang H., Li H.B., Lyu J.R., Lei X.M., Li W., Wu G. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int. J. Infect. Dis. 2020;96 PubMed PMC

Zhang W., Zhao Y., Zhang F., Wang Q., Li T., Liu Z., Wang J., Qin Y., Zhang X., Yan X., Zeng X., Zhang S. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin. Immunol. 2020;214:108393. PubMed PMC

Zhang Y., Xiao M., Zhang S., Xia P., Cao W., Jiang W., Chen H., Ding X., Zhao H., Zhang H., Wang C., Zhao J., Sun X., Tian R., Wu W., Wu D., Ma J., Chen Y., Zhang D., Xie J., Yan X., Zhou X., Liu Z., Wang J., Du B., Qin Y., Gao P., Qin X., Xu Y., Zhang W., Li T., Zhang F., Zhao Y., Li Y., Zhang S. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 2020;382 PubMed PMC

Zhang C., Shi L., Wang F.-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020;5:428–430. PubMed PMC

Zhang G., Zhang J., Wang B., Zhu X., Wang Q., Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir. Res. 2020;21:74. PubMed PMC

Zhao B., Ni C., Gao R., Wang Y., Yang L., Wei J., Lv T., Liang J., Zhang Q., Xu W., Xie Y., Wang X., Yuan Z., Liang J., Zhang R., Lin X. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell. 2020;11:771–775. PubMed PMC

Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. PubMed PMC

Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. PubMed PMC

Zhou Y., Wang M., Li Y., Wang P., Zhao P., Yang Z., Wang S., Zhang L., Li Z., Jia K., Zhong C., Li N., Yu Y., Hou J. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium. Immunol. Lett. 2021;237:33–41. PubMed PMC

Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. PubMed PMC

Zhu L., She Z.-G., Cheng X., Qin J.-J., Zhang X.-J., Cai J., Lei F., Wang H., Xie J., Wang W., Li H., Zhang P., Song X., Chen X., Xiang M., Zhang C., Bai L., Xiang D., Chen M.-M., Liu Y., Yan Y., Liu M., Mao W., Zou J., Liu L., Chen G., Luo P., Xiao B., Zhang C., Zhang Z., Lu Z., Wang J., Lu H., Xia X., Wang D., Liao X., Peng G., Ye P., Yang J., Yuan Y., Huang X., Guo J., Zhang B.-H., Li H. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068–1077.e1063. PubMed PMC

Zhugunissov K., Zakarya K., Khairullin B., Orynbayev M., Abduraimov Y., Kassenov M., Sultankulova K., Kerimbayev A., Nurabayev S., Myrzakhmetova B., Nakhanov A., Nurpeisova A., Chervyakova O., Assanzhanova N., Burashev Y., Mambetaliyev M., Azanbekova M., Kopeyev S., Kozhabergenov N., Issabek A., Tuyskanova M., Kutumbetov L. Development of the inactivated QazCovid-in vaccine: protective efficacy of the vaccine in Syrian hamsters. Front. Microbiol. 2021;12 PubMed PMC

Ziegler C.G.K., Allon S.J., Nyquist S.K., Mbano I.M., Miao V.N., Tzouanas C.N., Cao Y., Yousif A.S., Bals J., Hauser B.M. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016–1035. PubMed PMC

Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 2020;14:185–192. PubMed PMC

Zulfiqar A.-A., Lorenzo-Villalba N., Hassler P., Andrès E. Immune thrombocytopenic purpura in a patient with Covid-19. N. Engl. J. Med. 2020;382 PubMed PMC

Zuo Y., Yalavarthi S., Shi H., Gockman K., Zuo M., Madison J.A., Blair C., Weber A., Barnes B.J., Egeblad M., Woods R.J., Kanthi Y., Knight J.S. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020:5. PubMed PMC